Literature DB >> 17080195

Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.

Foteini Mourkioti1, Paschalis Kratsios, Tom Luedde, Yao-Hua Song, Patrick Delafontaine, Raffaella Adami, Valeria Parente, Roberto Bottinelli, Manolis Pasparakis, Nadia Rosenthal.   

Abstract

NF-kappaB is a major pleiotropic transcription factor modulating immune, inflammatory, cell survival, and proliferative responses, yet the relevance of NF-kappaB signaling in muscle physiology and disease is less well documented. Here we show that muscle-restricted NF-kappaB inhibition in mice, through targeted deletion of the activating kinase inhibitor of NF-kappaB kinase 2 (IKK2), shifted muscle fiber distribution and improved muscle force. In response to denervation, IKK2 depletion protected against atrophy, maintaining fiber type, size, and strength, increasing protein synthesis, and decreasing protein degradation. IKK2-depleted mice with a muscle-specific transgene expressing a local Igf-1 isoform (mIgf-1) showed enhanced protection against muscle atrophy. In response to muscle damage, IKK2 depletion facilitated skeletal muscle regeneration through enhanced satellite cell activation and reduced fibrosis. Our results establish IKK2/NF-kappaB signaling as an important modulator of muscle homeostasis and suggest a combined role for IKK inhibitors and growth factors in the therapy of muscle diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080195      PMCID: PMC1626136          DOI: 10.1172/JCI28721

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

Authors:  C Rommel; S C Bodine; B A Clarke; R Rossman; L Nunez; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

3.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.

Authors:  S C Bodine; T N Stitt; M Gonzalez; W O Kline; G L Stover; R Bauerlein; E Zlotchenko; A Scrimgeour; J C Lawrence; D J Glass; G D Yancopoulos
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

5.  TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.

Authors:  Dario Coletti; Ellen Yang; Giovanna Marazzi; David Sassoon
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy.

Authors:  R Bridge Hunter; EricJ Stevenson; Alan Koncarevic; Heather Mitchell-Felton; David A Essig; Susan C Kandarian
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

7.  The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(-/-) and TNF-alpha(-/-)/LT-alpha(-/-) mice.

Authors:  R A Collins; M D Grounds
Journal:  J Histochem Cytochem       Date:  2001-08       Impact factor: 2.479

8.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

9.  Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

Authors:  R C Langen; A M Schols; M C Kelders; E F Wouters; Y M Janssen-Heininger
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

Review 10.  Control of muscle size during disuse, disease, and aging.

Authors:  H Degens; S E Alway
Journal:  Int J Sports Med       Date:  2006-02       Impact factor: 3.118

View more
  137 in total

1.  Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Pradyut K Paul; Shihuan Kuang; Ashok Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Toward an integrated research agenda for critical illness in aging.

Authors:  Eric B Milbrandt; Basil Eldadah; Susan Nayfield; Evan Hadley; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

3.  Science amongst the vines. Meeting on signalling systems.

Authors:  Stuart M Pitson; Gregory J Goodall; Mark A Guthridge
Journal:  EMBO Rep       Date:  2008-04-11       Impact factor: 8.807

4.  SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth.

Authors:  Donghoon Lee; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

5.  Neuronal Ablation of IKK2 Decreases Lesion Size and Improves Functional Outcome after Spinal Cord Injury in Mice.

Authors:  Ditte Gry Ellman; Hans Gram Novrup; Louise Helskov Jørgensen; Minna Christiansen Lund; Minna Yli-Karjanmaa; Pernille Marie Madsen; Jonas Heinrich Vienhues; Safinaz Dursun; John R Bethea; Karin Lykke-Hartmann; Roberta Brambilla; Kate Lykke Lambertsen
Journal:  JSM Neurosurg Spine       Date:  2017-08-10

6.  Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.

Authors:  Sajedah M Hindi; Vivek Mishra; Shephali Bhatnagar; Marjan M Tajrishi; Yuji Ogura; Zhen Yan; Linda C Burkly; Timothy S Zheng; Ashok Kumar
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

7.  Impaired myogenesis in estrogen-related receptor γ (ERRγ)-deficient skeletal myocytes due to oxidative stress.

Authors:  Jennifer Murray; Johan Auwerx; Janice M Huss
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 8.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

9.  S100B protein in tissue development, repair and regeneration.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Claudia Tubaro; Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  World J Biol Chem       Date:  2013-02-26

Review 10.  Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy.

Authors:  Robert W Jackman; Evangeline W Cornwell; Chia-Ling Wu; Susan C Kandarian
Journal:  Exp Physiol       Date:  2012-07-30       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.